Connection

Ki Chung to Tegafur

Back to Details
This is a "connection" page, showing publications Ki Chung has written about Tegafur.
Ki Chung
Connection Strength
0.094
Tegafur
  1. Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors. Oncology. 2011; 81(2):65-72.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.